New CEO is a gun Highly qualified - educated to Phd level highly connected -20 years biotech space across various growth companies including board level MAyne Pharma highly experienced- held positions outside Australia in Europe
Really the above doesn't do him justice. The best thing to do is google his name and then make some calls.
Really the details of where he has been are only slightly relevant.
Its ts where he is going with ADAlta which we should be focussed on
Some low hanging fruit to be picked with ADAlta
Long runway ahead here
1AD Price at posting:
16.0¢ Sentiment: Buy Disclosure: Held
